Cargando…

Recent-onset atrial fibrillation: a study exploring the elements of Virchow’s triad after cardioversion

PURPOSE: Atrial fibrillation (AF) imposes an inherent risk for stroke and silent cerebral emboli, partly related to left atrial (LA) remodeling and activation of inflammatory and coagulation systems. The aim was to explore the effects of cardioversion (CV) and short-lasting AF on left atrial hemodyn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arvanitis, Panagiotis, Johansson, Anna-Karin, Frick, Mats, Malmborg, Helena, Gerovasileiou, Spyridon, Larsson, Elna-Marie, Blomström-Lundqvist, Carina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236986/ https://www.ncbi.nlm.nih.gov/pubmed/34689250 http://dx.doi.org/10.1007/s10840-021-01078-9

Ejemplares similares

Permanent left atrial thrombi after multiple atrial fibrillation ablations: Acquired Virchow’s triad?
por: Ali, Saif, et al.
Publicado: (2022)

Mechanistic modelling of Virchows triad to assess thrombogenicity and stroke risk in atrial fibrillation patients
por: Qureshi, A, et al.
Publicado: (2022)

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
por: Lenhoff, Hanna, et al.
Publicado: (2021)

Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF Stroke Prophylaxis
por: Darlington, Ashley, et al.
Publicado: (2020)

Left atrial function after epicardial pulmonary vein isolation in patients with atrial fibrillation
por: Bagge, Louise, et al.
Publicado: (2017)

Catheter ablation of symptomatic atrial fibrillation: Sex, ethnicity, and socioeconomic disparities
por: Björkenheim, Anna, et al.
Publicado: (2022)

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report
por: Lundqvist, Carina Blomström, et al.
Publicado: (2021)

Virchow’s Triad and the Role of Thrombosis in COVID-Related Stroke
por: Gonzalez-Gonzalez, Francisco J., et al.
Publicado: (2021)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2008)

COVID‐19, thromboembolic risk, and Virchow's triad: Lesson from the past
por: Mehta, Jawahar L., et al.
Publicado: (2020)

The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow’s Triad
por: Anton, Aina, et al.
Publicado: (2022)

COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women
por: Carbillon, Lionel, et al.
Publicado: (2021)

The Role of Biphasic Shocks for Transthoracic Cardioversion of Atrial Fibrillation
por: Walsh, Simon J, et al.
Publicado: (2005)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
por: Vaisman, M, et al.
Publicado: (2005)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation
por: Younis, Arwa, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
por: Ahmed, Sakir, et al.
Publicado: (2020)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Utilization and Predictors of Electrical Cardioversion in Patients Hospitalized for Atrial Fibrillation
por: Rochlani, Yogita M., et al.
Publicado: (2016)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017)

Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation
por: van Vugt, S. P. G., et al.
Publicado: (2018)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
por: Höglund, Niklas, et al.
Publicado: (2017)

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p73d9bigak6hjdlsgrtcju2bms